A functional, nonfunctioning Retisert implant.
The fluocinolone acetonide (Retisert™) implant is an approved therapy for chronic, posterior, non-infectious uveitis. Continued episodes of inflammation can occur in patients after device implantation and suspected Retisert™ malfunction has been previously reported. We report a case of a patient who continued to have inflammation after Retisert™ implantation, which subsided after device exchange with a normally functioning explant after detailed manufacturer analysis.